Skip to Content

Vertical Peak Holdings Inc Ordinary Shares (New Sub Voting) SPLIF

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SPLIF is trading at a 52% discount.
Price
$0.00
Fair Value
$3.67
Uncertainty
Extreme
1-Star Price
$2.33
5-Star Price
$6.67
Economic Moat
Jcxx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SPLIF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.29
Bid/Ask
$0.00 / $0.25
Market Cap
$824,745.48
Volume/Avg
2,277 / 13,159

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.06
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Vertical Peak Holdings Inc is focused on developing and manufacturing branded products in the cannabis industry with a specific focus on flower, pre-rolls, vapes, edibles and oil extracts for medical and adult recreational use. Vertical Peak operates and controls licenses in California, which include manufacturing, retail and cultivation operations in California. Vertical Peak's main portfolio includes the OutCo and Thrive brands that it acquired in 2021 pursuant to the acquisition of the business of OutCo.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees

Valuation

Metric
SPLIF
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
0.06
Price/Cash Flow
Price/Earnings
SPLIF

Financial Strength

Metric
SPLIF
Quick Ratio
0.07
Current Ratio
0.22
Interest Coverage
−5.32
Quick Ratio
SPLIF

Profitability

Metric
SPLIF
Return on Assets (Normalized)
−36.05%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−42.18%
Return on Assets
SPLIF
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRFtszszyhMgbnqn$70.8 Bil
ZTS
Zoetis Inc Class AJjhvqwqgnRzl$68.9 Bil
HLN
Haleon PLC ADRPfcrhrlkbSwl$37.7 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRPjkrczmnjHyh$14.8 Bil
VTRS
Viatris IncNzpxbkzjTvxv$13.6 Bil
RDY
Dr Reddy's Laboratories Ltd ADRRycnjhknfTzyw$11.9 Bil
CTLT
Catalent IncJntvbglWhtynz$10.1 Bil
PRGO
Perrigo Co PLCGrpfxmdyZljy$4.3 Bil
CURLF
Curaleaf Holdings IncZbdhstnYrb$3.6 Bil
PBH
Prestige Consumer Healthcare IncKjybpqcXtqhys$3.5 Bil

Sponsor Center